Delivery Order SPE2DR25D3501-SPE2DR26FM2PL
- Not listed
- The Defense Logistics Agency awarded a $6,585.32 delivery order to AmerisourceBergen Drug Corp for 100 tablets of Ambien CR 6.25 mg, with an ultimate completion date of January 13, 2026. This contract was competitively awarded without set-aside designation under firm fixed-price terms. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, with its parent company being Cencora, Inc. (doing...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, received a $5.74K firm fixed-price delivery order from the Defense Logistics Agency (DLA) on November 17, 2025, for the supply of Ambien CR 6.25 mg tablets (100-count bottles). The contract, which carries no set-aside designation, represents a competitively awarded transaction with an ultimate completion date of November 18, 2025. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a delivery order valued at $1,606.04 to AmerisourceBergen Drug Corp for 100 tablets of Ambien CR 6.25 mg on January 15, 2026, with an ultimate completion date of January 16, 2026. This competitively awarded, non-set-aside contract involves firm fixed pricing and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc. (doing business as...
- The Defense Logistics Agency awarded a delivery order valued at $2,358.09 to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Ambien CR 12.5 mg tablets (100-count units). This firm fixed-price, non-set-aside contract is scheduled for completion by August 14, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a routine pharmaceutical procurement supporting federal medical supply requirements. This award is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $8,518.32 to AmerisourceBergen Drug Corp for the supply of Ambien CR 6.25 mg tablets (100-count units). This firm fixed-price contract, effective through December 12, 2025, represents a non-competitive delivery order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,331.08 for Ambien CR 6.25 mg tablets (100-count units) on September 23, 2025, with completion scheduled for September 24, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's broader pharmaceutical supply agreements with DLA. The pharmaceutical distributor will perform the delivery order from its corporate office...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a firm fixed price delivery order by the Defense Logistics Agency (DLA) on September 23, 2025, valued at $4,288.38 with an ultimate completion date of September 24, 2025. The contract is for the supply of Ambien CR 6.25 mg tablets in quantities of 100 units. This award represents a non-competitive delivery order issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $3,178.36 to AmerisourceBergen Drug Corp for the supply of Ambien CR 6.25 mg tablets in quantities of 100 units. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive pharmaceutical supply vehicle running through December 2026. The order is scheduled for completion...
- The Defense Logistics Agency awarded a $7,252.04 delivery order to AmerisourceBergen Drug Corp on December 16, 2025, for the supply of Ambien CR 6.25 mg tablets in quantities of 100 units. The contract carries a firm fixed price structure with no set-aside designation, indicating competitive award through open competition. Performance will be executed at the awardee's facility in Conshohocken, Pennsylvania, with an ultimate completion date of December 17, 2025. This delivery order is a child...
- The Defense Logistics Agency awarded a delivery order valued at $2,459.27 to AmerisourceBergen Drug Corp for the supply of Ambien CR 6.25 mg tablets (100-count units) on November 25, 2025, with completion expected by November 26, 2025. This non-competitive delivery order utilizes firm fixed-price pricing and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen Drug Corp's larger Indefinite...
- SPE2DR25D3501Indefinite Delivery Contract
- SPE2DR25D3501-SPE2DR26FM2PLDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,876.57 to AmerisourceBergen Drug Corp for the supply of Ambien CR 6.25 mg tablets (100-count units) on January 15, 2026, with an ultimate completion date of January 16, 2026. This firm fixed-price delivery order represents a non-set-aside, competitively awarded contract with performance to be fulfilled from the contractor's location in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, a $999,999,999.00 global pharmaceutical support vehicle running through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc. (doing business as AmerisourceBergen), is a major pharmaceutical distributor and healthcare solutions provider serving as a critical vendor for federal medical procurement needs, particularly for military and veteran healthcare systems. The company's extensive federal contract portfolio demonstrates its capability to efficiently fulfill government requirements for essential pharmaceutical and medical commodities across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, vaccines, and medical supplies. This delivery order exemplifies the company's ongoing role in supporting the Defense Health Agency and other federal healthcare systems through flexible and competitively awarded contract vehicles.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 1/14/26 |